Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2 Biotechs Absolutely Crushing It
Motley Fool
Friday, April 20, 2012 - 9:26am
tags:
Human Genome Sciences, Gilead
Human Genome Sciences - Investors Are Speculating On A Higher Bid
Seeking Alpha
Friday, April 20, 2012 - 9:25am
tags:
Human Genome Sciences, GSK, M&A
Bristol-Myers' Daclatasvir, Asunaprevir Cured 77%: Study
Bloomberg
Thursday, April 19, 2012 - 1:03pm
tags:
daclatasvir, asunaprevir, Bristol-Myers Squibb, hepatitis C
Earnings Preview: Amgen
Yahoo/Zacks
Thursday, April 19, 2012 - 1:02pm
tags:
Amgen, earnings
Amgen To Assume Certain Pfizer Sales Duties For Enbrel In US
NASDAQ.com
Thursday, April 19, 2012 - 11:51am
tags:
Amgen, Pfizer, Enbrel
BioTime: A Track Record Of Broken Promises
Seeking Alpha
Thursday, April 19, 2012 - 11:50am
tags:
BioTime
Johnson & Johnson Raises Forecast; Will Other Drug Companies Follow Suit?
Motley Fool
Thursday, April 19, 2012 - 11:48am
tags:
JNJ, guidance
Forest Labs Earnings Call Nuggets: Guidance and New Product Catalysts
Wall St. Cheat Sheet
Thursday, April 19, 2012 - 11:47am
tags:
earnings, guidance, Forest Labs
Cubist Earnings Narrowly Exceed Expectations
Investors.com
Thursday, April 19, 2012 - 11:46am
tags:
earnings, Cubist
Valeant, Depomed Sue Watson Over Patents for Diabetes Drug
Bloomberg
Thursday, April 19, 2012 - 11:45am
tags:
Depomed, Watson Pharmaceuticals, Valeant Pharmaceuticals, diabetes, generics, Glumetza
Gilead Rises After Hepatitis Data Open New Test Options
Bloomberg
Thursday, April 19, 2012 - 11:43am
tags:
hepatitis C, Gilead, Bristol-Myers Squibb, GS-7977
Merck Unit’s Plea Over Vioxx Investigation Accepted by Judge
Bloomberg
Thursday, April 19, 2012 - 11:42am
tags:
Merck, Vioxx
Bristol-Myers shares likely to pull back after conference, says MKM Partners
The Fly on the Wall
Thursday, April 19, 2012 - 11:42am
tags:
Bristol-Myers Squibb
AstraZeneca Will Tumble If New Dutoprol Drug Fails
Seeking Alpha
Thursday, April 19, 2012 - 10:58am
tags:
AstraZeneca, Dutoprol, Amgen, Bristol-Myers Squibb, GSK, Merck, Targacept, antihypertensives
Johnson & Johnson Will Tumble On Risperdal Lawsuit, Bad PR
Seeking Alpha
Thursday, April 19, 2012 - 10:41am
tags:
JNJ, Risperdal
Merck says it won its 5th Fosamax lawsuit
Yahoo/AP
Thursday, April 19, 2012 - 10:38am
tags:
Merck, Fosamax
Human Genome jumps 109%, above GSK's $13 per share offer price
Yahoo/Fly on the Wall
Thursday, April 19, 2012 - 10:37am
tags:
Human Genome Sciences, GSK
Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Bloomberg
Thursday, April 19, 2012 - 10:36am
tags:
Boehringer Ingelheim, hepatitis C, BI 201335, protease inhibitors, nucleoside polymerase inhibitor, BI 207127
EU OKs J&J's $21.3B Synthes Takeover: Hot Trends
TheStreet.com
Thursday, April 19, 2012 - 10:35am
tags:
Europe, JNJ, Synthes, M&A
Human Genome Sciences Rejects $2.59 Billion Offer From GlaxoSmithKline
NY Times, NY
Thursday, April 19, 2012 - 10:34am
tags:
Human Genome Sciences, GSK, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.